AMGEN INC. v. APOTEX INC.

2016-1308.

827 F.3d 1052 (2016)

AMGEN INC., Amgen Manufacturing Limited, Plaintiffs-Appellees v. APOTEX INC., Apotex Corp., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: July 5, 2016.


Attorney(s) appearing for the Case

NICHOLAS P. GROOMBRIDGE , Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, NY, argued for plaintiffs-appellees. Also represented by ERIC ALAN STONE , CATHERINE NYARADY , JENNIFER GORDON , PETER SANDEL , JENNIFER H. WU , STEPHEN ACCURSIO MANISCALCO ; WENDY A. WHITEFORD , LOIS M. KWASIGROCH , KIMBERLIN L. MORLEY , Amgen Inc., Thousand Oaks, CA; JOHN F. O'SULLIVAN , ALLEN P. PEGG , JASON STERNBERG , Hogan Lovells US LLP, Miami, FL.

KERRY BRENDAN McTIGUE , Cozen O'Connor, Washington, DC, argued for defendants-appellants. Also represented by AARON S. LUKAS , WILLIAM BLAKE COBLENTZ , BARRY P. GOLOB , DONALD R. McPHAIL ; JOHN CHRISTOPHER ROZENDAAL , DAVID CHARLES FREDERICK, MILES SWEET , Kellogg, Huber, Hansen, Todd, Evans & Figel, PLLC, Washington, DC.

CARLOS T. ANGULO , Zuckerman Spaeder LLP, Washington, DC, for amicus curiae Biosimilars Council.

WILLIAM A. RAKOCZY , Rakoczy Molino Mazzochi Siwik LLP, Chicago, IL, for amicus curiae Mylan Inc. Also represented by LARA E. FITZSIMMONS .

CHARLES B. KLEIN , Winston & Strawn LLP, Washington, DC, for amici curiae Hospira, Inc., Celltrion Healthcare Co., Ltd., Celltrion, Inc. Also represented by STEFFEN NATHANAEL JOHNSON , ANDREW CURTIS NICHOLS ; SAMUEL S. PARK , DAN HOANG, Chicago, IL.

GREGORY DISKANT , Patterson Belknap Webb & Tyler LLP, New York, NY, for amicus curiae Janssen Biotech, Inc. Also represented by IRENA ROYZMAN , ARON RUSSELL FISCHER .

LISA BARONS PENSABENE , O'Melveny & Myers LLP, New York, NY, for amicus curiae Biotechnology Innovation Organization. Also represented by FILKO PRUGO , DANIEL BENJAMIN O'BOYLE ; DEANNA MARIE RICE , Washington, DC.

Before WALLACH, BRYSON, and TARANTO, Circuit Judges.


This appeal involves an action brought by Amgen Inc. and Amgen Manufacturing Limited (collectively Amgen) against Apotex Inc. and Apotex Corp. (collectively Apotex) under the Biologics Price Competition and Innovation Act of 2009 (Biologics Act or BPCIA). Apotex has an application pending with the Food and Drug Administration...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases